Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Mao

Showing results (601-610 of 618) with videos related to

Pageof 62
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) studyJian Zeng, Wei-Min Mao, Qi-Xun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III TrialWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Cancer|November 13, 2019
Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analysesXiao Hu, Yong Bao, Yu-Jin Xu, et al.
Surgical Endoscopy|December 23, 2025
Impact of hospital volume on outcomes of esophagectomy for esophageal cancer: analysis of a prospective multicenter databaseYou-Sheng Mao, Shu-Geng Gao, Fu-Shun Guan, et al.
Cancer Cell|April 19, 2024
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalizationWenying Wang, Tianran Li, Yue Cheng, et al.
Annals of Translational Medicine|September 16, 2022
Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501)You-Sheng Mao, Shu-Geng Gao, Yin Li, et al.
Frontiers in Oncology|November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in ChinaWeiping Liu, Donglu Zhao, Ting Liu, et al.
Journal of Digestive Diseases|April 8, 2025
Chinese Guideline for the Diagnosis and Management of Drug-Induced Liver Injury in Primary Care (2024)Yi Min Mao, Jie Ting Tang, Zhong Hua Lu, et al.
Nature Communications|November 9, 2021
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomesSi-Yang Liu, Hua Bao, Qun Wang, et al.
Cell Discovery|December 9, 2022
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in WuhanHong Liang, Xuanxuan Nian, Junzheng Wu, et al.
Pageof 62

Showing results (601-610 of 618) with videos related to

Sort By:
Pageof 62
Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) studyJian Zeng, Wei-Min Mao, Qi-Xun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III TrialWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Cancer|November 13, 2019
Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analysesXiao Hu, Yong Bao, Yu-Jin Xu, et al.
Surgical Endoscopy|December 23, 2025
Impact of hospital volume on outcomes of esophagectomy for esophageal cancer: analysis of a prospective multicenter databaseYou-Sheng Mao, Shu-Geng Gao, Fu-Shun Guan, et al.
Cancer Cell|April 19, 2024
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalizationWenying Wang, Tianran Li, Yue Cheng, et al.
Annals of Translational Medicine|September 16, 2022
Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501)You-Sheng Mao, Shu-Geng Gao, Yin Li, et al.
Frontiers in Oncology|November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in ChinaWeiping Liu, Donglu Zhao, Ting Liu, et al.
Journal of Digestive Diseases|April 8, 2025
Chinese Guideline for the Diagnosis and Management of Drug-Induced Liver Injury in Primary Care (2024)Yi Min Mao, Jie Ting Tang, Zhong Hua Lu, et al.
Nature Communications|November 9, 2021
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomesSi-Yang Liu, Hua Bao, Qun Wang, et al.
Cell Discovery|December 9, 2022
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in WuhanHong Liang, Xuanxuan Nian, Junzheng Wu, et al.
Pageof 62